摘要 |
<p>CASB611, CASB500, CASB501, CASB502, CASB505, or CASB507 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB611, CASB500, CASB501, CASB502, CASB505, or CASB507 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colon cancers, autoimmune diseases, and related conditions.</p> |